Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Pediatric Hematology/Oncology
CML
Questions discussed in this category
Would you change therapy for a CML patient in hematologic remission on imatinib found with positive qualitative BCR-ABL1 for the p230 protein?
qPCR for BCR/ABL was negative. FISH remained positive.
1 Answer available
Do you recommend continued PCR testing in a CML patient who underwent allogeneic stem cell transplantation with an identical match about 20 years ago?
1 Answer available
Do you switch from imatinib to another TKI in patients with chronic phase CML who develop renal insufficiency?
There are conflicting reports whether it contributes to renal insufficiency. If you do switch, what is your preferred TKI in this scenario?
2 Answers available
Should a teenager diagnosed with CML in blast crisis go to transplant once MRD is negative?
2 Answers available
20730
16382
15224
9910
Papers discussed in this category
Biol Blood Marrow Transplant, 2019 Jul 01
Allogeneic Stem Cell Transplantation for Blast Crisis Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: A Retrospective Study by the EBMT Chronic Malignancies Working Party.
Ann Hematol, 2015 Mar 27
Management of chronic myeloid leukemia in blast crisis.
Leukemia, 2008-12
Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase.
J Clin Pharmacol, 2021 Jul 16
Pharmacokinetics of Asciminib in Individuals With Hepatic or Renal Impairment.
Leukemia, 2023 Sep 19
Survival with chronic myeloid leukaemia after failing milestones.
Related Topics in Pediatric Hematology/Oncology
Lung Cancer
Breast Cancer
Head and Neck Cancers
Hematologic Malignancies
Radiation Oncology
Gynecologic Cancers
Palliation
Neuro-Oncology
Gastrointestinal Cancers
Genitourinary Cancers